Normal human bone marrow CD34+CD133+ cells contain primitive cells able to produce different categories of colony-forming unit megakaryocytes in vitro

Experimental Hematology

Volumn 30, Issue 9, 2002, Pages 1051-1060

  Charrier, Sabine ^a   Boiret, Nathalie ^a   Fouassier, Marc ^a   Berger, Juliette ^a   Rapatel, Chantal ^a   Pigeon, Pascale ^a   Mareynat, Gabrielle ^a   Bonhomme, Jean ^a   Camilleri, Lionel ^a   Berger, Marc Gabriel ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD133 ANTIGEN; CD34 ANTIGEN; FIBRINOGEN RECEPTOR; FLT3 LIGAND; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL ASSAY; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CLONOGENIC ASSAY; COLONY FORMING UNIT; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; LIQUID CULTURE; MEGAKARYOCYTE; PREDICTION; PRIORITY JOURNAL; STEM CELL; THROMBOCYTE; UPREGULATION;

ANTIGENS, CD; ANTIGENS, CD34; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL SEPARATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA, SERUM-FREE; ERYTHROID PROGENITOR CELLS; GLYCOPROTEINS; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; PEPTIDES; PLATELET MEMBRANE GLYCOPROTEIN IIB;

EID: 18644368571     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00882-2     Document Type: Article

References (64)

1. + cell dose in blood cell transplantation for cancer therapy. J Clin Oncol. 18:2000;1360.
2. + cell immunoselection from G-CSF-alone-primed peripheral blood in children with low body mass. Br J Haematol. 91:1995;431.
3. + cell transplantation procedure using standard leukapheresis products in very small children. Bone Marrow Transplant. 191:1997;8.
4. + selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood. 93:1999;1858.
5. + peripheral blood progenitors and growth factors on engraftment J Clin Oncol. 12:1994;28.
6. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood. 85:1995;1647.
7. + cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescue. Bone Marrow Transplant. 18:1996;871.
8. + cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. J Clin Oncol. 13:1995;1922.
9. Takamutsu Y., Harada M., Teshima T.et al. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation. Exp Hematol. 23:1995;8.
10. +/CD41a cells best predict platelet recovery after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 21:1998;1217.
11. + megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant. Bone Marrow Transplant. 23:1999;539.
12. Hogge D.E., Lambie K., Sutherland H.J.et al. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant. Bone Marrow Transplant. 25:2000;589.
13. + peripheral blood progenitor cells evaluated with an adapted serum-free methylcellulose assay, is predictive of p lineage reconstitution in children with solid tumors. J Hematother Stem Res. 525:2000;34.
14. Hogge D., Fanning S., Bockhold K.et al. Quantitation and characterization of human megakaryocyte colony-forming cells using a standardized serum-free agarose assay. Br J Haematol. 96:1997;790.
15. Reiffers J., Cailliot C., Dazey B., Attal M., Caraux J., Boiron J.-M. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet. 354:1999;1092.
16. McNiece I., Jones R., Bearman S.I.et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood. 96:2000;3001.
17. Paquette R.L., Dergham S.T., Karpf E.et al. Ex vivo expanded unselected peripheral blood. progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer Blood. 96:2000;2385.
18. Stiff P., Chen B., Franklin W.et al. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood. 95:2000;2169.
19. Paquette R.L., Dergham S.T., Karpf E.et al. Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery. Exp Hematol. 30:2002;374.
20. Bertolini F., Battaglia M., Pedrazzoli P.et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood. 89:1997;2679.
21. Miraglia S., Godfrey W., Yin A.H.et al. A novel five-transmembrane hematopoietic stem cell antigen. isolation characterization and molecular cloning Blood. 90:1997;5013.
22. Yin A.H., Miraglia S., Zanjani E.D.et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 90:1997;5002.
23. Baersch G., Baumann M., Ritter J., Jurgens H., Vormoor J. Expression of AC133 and CD117 on candidate normal stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia. Br J Haematol. 107:1999;572.
24. Lee S.T., Jang J.H., Min Y.H., Hahn J.S., Ko Y.W. AC133 antigen as a prognostic factor in acute leukemia. Leuk Res. 757:2001;67.
25. Kobayashi M., Laver J.H., Kato T., Miyazaki H., Ogawa M. Thrombopoietin supports proliferation of human primitive hematopoietic cells in surgery with steel factor and/or interleukin-3. Blood. 88:1996;429.
26. Petzer A.L., Hogge D.E., Lansdorp P.M., Reid D.S., Eaves C.J. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci U S A. 93:1996;1470.
27. -) human hematopoietic cells. novel responses to Flt3-ligand and thrombopoietin J Exp Med. 183:1996;2551.
28. - bone marrow cells with multilineage potential at the single-cell level. key role of thrombopoietin Blood. 90:1997;2282.
29. Zandstra P.W., Conneally E., Petzer A.L., Piret J.M., Eaves C.J. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Prod Natl Acad Sci U S A. 94:1997;4698.
30. Bruno E., Briddell R., Hoffman R. Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation. Exp Hematol. 16:1988;371.
31. Wendling F., Maraskovsky E., Debili N.et al. CMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature. 369:1994;571.
32. Broudy V.C., Lin N.L., Kaushansky K. Thrombopoietic (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood. 85:1995;1719.
33. Piacibello W., Garetto L., Sanavio F.et al. The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis. Exp Hematol. 24:1996;340.
34. Li K., Yang M., Carmen A., Yau F.W., Yuen P.M.P. Effects of Flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors. Cell Transplant. 9:2000;125.
35. + cell selection for ex vivo expansion of hematopoietic stem cells. J Hematother Stem Cell Res. 10:2001;273.
36. Matsumoto K., Yasui K., Yamashito N.et al. In vitro proliferation potential of AC133 positive cells in peripheral blood. Stem Cells. 18:2000;196.
37. + cells from human umbilical cord. Br J Haematol. 108:2000;793.
38. Bhatia M. AC133 expression in human stem cells. Leukemia. 15:2001;1685.
39. Majka M., Ratajczak J., Machalinski B.et al. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells. Folia Histochem Cytobiol. 38:2000;53.
40. + cells during immunomagnetic separation. Br J Haematol. 105:1999;780.
41. Dorrell C., Gan O.I., Pereira D.S., Hawley R.G., Dick J.E. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency. dissociation of SRC phenotype and function Blood. 95:2000;102.
42. Danet G.H., Lee H.W., Luongo J.L., Simon M.C., Bonnet D.A. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion. Exp Hematol. 29:2001;1465.
43. Horn P.A., Tesch H., Staib P., Kube D., Diehl V., Voliotis D. Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells (letter). Blood. 93:1999;1435.
44. - hematopoietic stem cells using cell surface markers AC133 and CD7. Blood. 95:2000;2813.
45. Phillips D.R., Charo I.F., Parise L.V., Fitzgerald L.A. The platelet membrane glycoprotein IIb-IIIa complex. Blood. 71:1988;831.
46. Lopez J. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis. 5:1994;97.
47. Debili N., Issaad C., Masse J.M.et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood. 80:1992;3022.
48. Vinci G., Tabilio A., Deschamps J.F.et al. Immunological study of in vitro maturation of human megakaryocytes. Br J Haematol. 56:1984;589.
49. Debili N., Kieffer N., Nakazawa M. Expression of platelet glycoprotein Ib by cultured human megakaryocytes. ultrastructural localization and biosynthesis Blood. 76:1990;368.
50. + cord blood cells to megakaryocytes. Blood. 96:2000;4169.
51. Verfaillie C.M. Meeting report on an NHLBI workshop on ex vivo expansion of stem cells, July 29, 1999, Washington, D.C. Exp Hematol. 28:2000;361.
52. Van den Oudenrijn S., de Haas M., Calafat J., van der Schoot C.E., von dem Borne A.E.G.K. A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes. Br J Haematol. 106:1999;553.
53. + progenitor cells from bone marrow and G-CSF-mobilized peripheral blood Exp Hematol. 25:1997;1125.
54. Williams J.L., Pipia G.G., Datta N.S., Long M.W. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood. 91:1998;4118.
55. + stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol. 28:2000;1054.
56. Doshi P.D., Giri J.G., Abegg A.L.et al. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways. Exp Hematol. 29:2001;1177.
57. Blair A., Baker C.L., Pamphilon D.H., Judson P.A. Ex vivo expansion of megakaryocyte progenitor cells from normal bone marrow and peripheral blood and from patients with haematological malignancies. Br J Haematol. 116:2002;912.
58. Debili N., Robin C., Schiavon V.et al. Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates. Blood. 97:2001;2023.
59. Berridge M.V., Ralph S.J., Tan A.S. Cell-lineage antigens of the stem cell-megakaryocyte-platelet lineage are associated with the platelet IIb-IIIa glycoprotein complex. Blood. 66:1985;76.
60. Higuchi T., Koike K., Sawai N., Koike T. Proliferative and differentiative potential of thrombopoietin-responsive precursors. expression of megakaryocytic and erythroid lineages Exp Hematol. 25:1997;463.
61. Basch R.S., Zhang X.M., Dolzhanskiy A., Karpatkin S. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development. Br J Haematol. 105:1999;1044.
62. Holyoake T.L., Alcorn M.J., Richmond L.et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant. 19:1997;1095.
63. Pecora A.L., Stiff P., Jennis A.et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant. 25:2000;797.
64. + cells provides an in vivo model for human megakaryocytopoiesis and platelet production. Blood. 97:2001;1635.